Serial immunoprecipitation assays for interferon - (IFN)-β antibodies in multiple sclerosis patients

Vito Lampasona, Jordi Rio, Diego Franciotta, Roberto Furlan, Carlo Avolio, Raffaella Fazio, Vito Lavolpe, Angela Vincent, Giancarlo Comi, Maria Trojano, Xavier Montalban, Gianvito Martino

Research output: Contribution to journalArticlepeer-review


We devised a sensitive, radioimmunoprecipitation assay (RIPA) for anti-interferon (IFN)-P - binding antibody (BAB) detection. Our RIPA showed good agreement with a reference RIPA (mean difference, - 3.2 ± 10.6 AU), and detected BAB to both IFN-β-1a and IFN-β-1b. Neutralizing antibodies to IFN-β (NAB) were also determined with a standard method. BAB and NAB were measured in 393 serum samples from 77 multiple sclerosis (MS) patients treated with IFN-β-1a or -1b, who were studied over two years, and subsequently classified as responders and non-responders. BAB were found at higher concentrations, and more frequently detected, in IFN-β-1b- than in IFN-β-1a-treated patients, and, at highest titres, preferentially in patients who were positive for NAB. However, in our series of MS patients, both titres and frequency of detection of BAB or NAB did not differ between IFN-β responders and non-responders.

Original languageEnglish
Pages (from-to)154-157
Number of pages4
JournalEuropean Cytokine Network
Issue number3
Publication statusPublished - Jul 2003


  • Anti-IFN-β antibodies
  • Binding antibodies
  • IFN-β,
  • Multiple sclerosis

ASJC Scopus subject areas

  • Immunology
  • Cell Biology


Dive into the research topics of 'Serial immunoprecipitation assays for interferon - (IFN)-β antibodies in multiple sclerosis patients'. Together they form a unique fingerprint.

Cite this